Patent · US Active

PSMA targeted compounds and uses thereof

US11998620B2 · kind B2 · utility

0Cited by
60References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 28, 2023
Grant dateJun 4, 2024
Priority date
Expiry dateAug 28, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

PSMA targeted compounds, pharmaceutical compositions comprising these compounds, and methods for treating and detecting cancers in a subject are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.